Evidence map›Paper›PMID 26080650›Full record

ArticlePediatric diabetes2016

Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes.

Melanie Cree-Green, David M Maahs, Annie Ferland, John E Hokanson, Hong Wang, Laura Pyle, Gregory L Kinney, Martina King, Robert H Eckel, Kristen J Nadeau

Open access · greenAbstract read
In one paragraph

Article in Pediatric diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2019
    Trial
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Lipid management for cardiovascular risk reduction in type 1 diabetes.Current opinion in endocrinology, diabetes, and obesity · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance.The Journal of clinical endocrinology and metabolism · 2018
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Melanie Cree-GreenBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
David M MaahsBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Annie FerlandDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
John E HokansonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Hong WangDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Laura PyleDepartment of Pediatrics, Division of Pediatric Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Gregory L KinneyDepartment of Pediatrics, Division of Pediatric Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Martina KingDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Robert H EckelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kristen J NadeauBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
University of Colorado Anschutz Medical Campus · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI CONNICK, ELIZABETH · 1985 to 2008
$52.6M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BRYAN C BERGMAN · 1995 to 2026
$32.6M
ZORVIRAX ORAL SUSPENSION FOR SEVERE CHILDHOOD HERPES VIRUS INFECTIONSM01RR000069 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 1985 to 2008
$22.1M
UCHSC: Building Interdisciplinary Research Careers in Women's HealthK12HD057022 · NICHD · UNIVERSITY OF COLORADO DENVER · PI REGENSTEINER, JUDITH G., SANTORO, NANETTE F. · 2007 to 2023
$8.5M
Training Program in Diabetes ResearchT32DK063687 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Andrea Steck · 2002 to 2026
$5.2M
Colorado Clinical and Translational Sciences InstituteTL1TR001081 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$1.3M
Colorado Clinical and Translational Science Institute (TL1)TL1RR025778 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$730k
Insulin Control of Fat Regulation and Exercise in TeensK23RR020038 · NCRR · UNIVERSITY OF COLORADO DENVER · PI NADEAU, KRISTEN JANE · 2004 to 2008
$657k
Insulin Resistance In Adolescents With Diabetes: A New Frontier For CardiovasculaR56DK088971 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NADEAU, KRISTEN JANE · 2010 to 2010
$215k
NCATS NIH HHS TL1 TR001081NCATS NIH HHS UL1 TR001082NCRR NIH HHS K23 RR020038NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR000069NCRR NIH HHS TL1 RR025778NCRR NIH HHS UL1 RR025780NICHD NIH HHS K12 HD057022NIDDK NIH HHS R56 DK088971NIDDK NIH HHS T32 DK063687
6 · The paper itself

Abstract

aims/hypothesisAdolescents with type 1 diabetes (T1D) often have a less atherogenic-appearing fasting lipid profile than controls, despite increased rates of cardiovascular disease (CVD) as adults. We previously reported an atherogenic lipoprotein subfraction cholesterol distribution associated with insulin resistance (IR) in T1D adults. We sought to determine if T1D youth have more atherogenic profile than controls via a cross-sectional study.

methodsFollowing 3 days of controlled diet and restricted exercise, fasting plasma samples were drawn from 28 T1D youth [50% female, age 15.3 ± 2 yr, body mass index (BMI) 48%ile; diabetes duration 73 ± 52 months, hemoglobin A1c (HbA1c) 8.3 ± 1.4%] and 17 non-diabetic controls (47% female, age: 15.0 ± 2 yr, BMI 49%ile) prior to a hyperinsulinemic euglycemic clamp. Lipoproteins were fractionated by fast protein liquid chromatography (FPLC) and lipoprotein cholesterol distribution determined. Outcome measures were IR assessed by glucose infusion rate (GIR) and FPLC lipoprotein subfraction cholesterol distribution.

resultsT1D youth were more IR (GIR 9.1 ± 3.6 vs. 14.7 ± 3.9 mg/kg/min, p < 0.0001) and had more cholesterol distributed as small dense low density lipoprotein-cholesterol (LDL-C) and less as large buoyant high density lipoprotein-cholesterol (HDL-C) than controls (p < 0.05), despite no differences in the fasting lipid panel. T1D girls lacked the typical female less-atherogenic profile, whereas control girls tended to have a shift toward less dense LDL-C and HDL-C vs. control boys. Among T1D, IR but not HbA1c was associated with a more atherogenic lipoprotein profile. CONCLUSIONS/INTERPRETATIONS: Normal weight T1D youth, especially females, had more atherogenic LDL-C and HDL-C distributions which correlated with lower insulin sensitivity. IR may contribute to the increased CVD burden in T1D.

Indexed as

AdolescentBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 1FemaleHumansInsulin ResistanceLipoproteinsMaleSex FactorsBlood GlucoseLipoproteinscardiovascular diseaseinsulin resistancelipidspediatricstype 1 diabetes

Identifiers

PMID26080650
PMCPMC4887262
OpenAlexW2163332836

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.